Flow-Controlled vs. Pressure-Controlled Ventilation in CABG: Effects on Lung Aeration and Diaphragm Function

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKoşuyolu Kartal Heart Training and Research Hospital

About this trial

Pulmonary atelectasis and loss of lung aeration are common complications following cardiac surgery with cardiopulmonary bypass (CPB) and are associated with impaired oxygenation and prolonged mechanical ventilation. Diaphragm dysfunction occurring in the perioperative period may further delay extubation and prolong intensive care unit (ICU) stay. Flow-Controlled Ventilation (FCV) is a novel ventilation modality that provides continuous, flow-based delivery of tidal breaths with a triangular flow profile, potentially offering superior dynamic compliance optimisation compared to conventional Pressure-Controlled Ventilation (PCV).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

Planned elective isolated on-pump coronary artery bypass graft (CABG) surgery

ASA Physical Status Classification II-IV

Written informed consent obtained

Disqualifiers

Emergency surgery

Combined surgical procedures (e.g., valve repair/replacement + CABG)

Preoperative requirement for invasive or non-invasive mechanical ventilation

Known diaphragm paralysis or neuromuscular disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Flow-Controlled Ventilation

    Procedure/Surgery

    FCV delivers tidal ventilation via a continuous triangular flow waveform, maintaining constant inspiratory and expiratory flow rates throughout the entire respiratory cycle. PEEP and peak airway pressure are titrated independently, guided by dynamic respiratory system compliance. Tidal volume target is 6-8 mL/kg ideal body weight. This ventilation modality is distinct from pressure-controlled and volume-controlled modes, which generate decelerating inspiratory flow profiles and do not allow simultaneous independent titration of PEEP and peak airway pressure based on compliance.

  • Pressure-Controlled Ventilation (PCV)

    Procedure/Surgery

    PCV is delivered using a standard anaesthesia workstation in pressure-controlled mode. Inspiratory pressure is set to achieve a tidal volume of 6-8 mL/kg ideal body weight. PEEP is titrated using the same compliance-guided algorithm applied in the FCV arm. Unlike FCV, the inspiratory flow profile is decelerating and PEEP and peak airway pressure are not independently optimised in a compliance-guided manner within the same ventilation mode

Treatment groups

154 Participants
are divided into 2 treatment groups
Group A: FCV (Flow-Controlled Ventilation)Experimental treatment 1 intervention
Group B: PCV (Pressure-Controlled Ventilation)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Total Lung Ultrasound Score (LUS)

Lung aeration assessed using a 12-zone bilateral ultrasonography protocol. Each zone scored 0-3 (0 = normal aeration with A-lines; 1 = multiple B-lines; 2 = coalescent B-lines; 3 = consolidation). Total score ranges from 0 to 36; higher scores indicate greater aeration loss

Time frame
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)

Secondary outcomes

1

Diaphragm Thickening Fraction (TFdi)

Bilateral diaphragm thickening fraction measured via B-mode and M-mode ultrasonography at the zone of apposition using a linear probe (7-12 MHz). TFdi (%) = \[(T\_insp - T\_exp) / T\_exp\] × 100.

Time frame
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
2

Diaphragm Excursion

Bilateral inspiratory diaphragm dome displacement measured via M-mode ultrasonography using a convex probe (2-5 MHz) via subcostal approach.

Time frame
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
3

PaO₂/FiO₂ Ratio

Ratio of arterial oxygen partial pressure to fractional inspired oxygen, calculated from arterial blood gas analysis.

Time frame
Preoperatively (T0), within 30 minutes of sternal closure while intubated (T1), and 24 hours postoperatively after extubation (T2)
4

Postoperative Pulmonary Complications

Composite of clinically significant pulmonary complications including radiologically confirmed atelectasis, pneumonia, and re-intubation, assessed according to pre-specified definitions.

Time frame
Up to 30 days postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: